Access cutting-edge chronic urticaria treatment through this clinical trial at a research site in San Diego. Study-provided care at no cost to qualified participants.
Access chronic urticaria specialists in San Diego at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic urticaria treatment provided free
The purpose of this trial is: 1. to assess the efficacy, pharmacokinetics, and safety of remibrutinib vs. placebo in adolescents from 12 to \< 18 years of age suffering from chronic spontaneous urticaria inadequately controlled by H1-antihistamines 2. to collect long-term efficacy, safety and tolerability data on remibrutinib in adolescents after having completed 24 weeks of treatment 3. to collect safety data in this population for up to three years after the last dose of study treatment
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this chronic urticaria clinical trial in San Diego, CA
If you're searching for chronic urticaria treatment options in San Diego, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Diego research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic urticaria specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.